TD Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Hold |
|
|||||
|
2025
Q1 | $466K | Sell |
|
|||||
|
2024
Q4 | $2.3M | Sell |
|
|||||
|
2024
Q3 | $3.55M | Buy |
|
|||||
|
2024
Q2 | $2.28M | Sell |
|
|||||
|
2024
Q1 | $7.49M | Buy |
|
|||||
|
2023
Q4 | $2.09M | Sell |
|
|||||
|
2023
Q3 | $1.53M | Buy |
|
|||||
|
2023
Q2 | $1.18M | Buy |
|
|||||
|
2023
Q1 | $713K | Buy |
|
|||||
|
2022
Q4 | $733K | Sell |
|
|||||
|
2022
Q3 | $1.41M | Buy |
|
|||||
|
2022
Q2 | $1.49M | Sell |
|
|||||
|
2022
Q1 | $2.68M | Buy |
|
|||||
|
2021
Q4 | $2.65M | Buy |
|
|||||
|
2021
Q3 | $3.24M | Hold |
|
|||||
|
2021
Q2 | $2.93M | Sell |
|
|||||
|
2021
Q1 | $5.04M | Sell |
|
|||||
|
2020
Q4 | $9.1M | Buy |
|
|||||
|
2020
Q3 | $5.67M | Hold |
|
|||||
|
2020
Q2 | $4.73M | Buy |
|
|||||
|
2020
Q1 | $4.69M | Sell |
|
|||||
|
2019
Q4 | $4.64M | Sell |
|
|||||
|
2019
Q3 | $3.13M | Buy |
|
|||||
|
2019
Q2 | $4.05M | Buy |
|
|||||
|
2019
Q1 | $1.04M | Sell |
|
|||||
|
2018
Q4 | $974K | Buy |
|
|||||
|
2018
Q3 | $1.15M | Buy |
|
|||||
|
2018
Q2 | $1.26M | Buy |
|
|||||
|
2018
Q1 | $1.29M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $123K | Buy |
|